Nureca Limited reported a significant operational turnaround for FY26, posting an operating profit of ₹8.5 crore against a loss last year. The company is also streamlining operations through a subsidiary merger.
Nureca Ltd Reports FY26 Turnaround, Eyes Operational Streamlining
Nureca Limited posted an operating profit of ₹8.5 crore for the fiscal year 2025-26, a notable shift from the ₹7.5 crore operating loss in the previous year. Revenue from operations stood at ₹146.96 crore, with a Gross Merchandise Value (GMV) of ₹203 crore projected for FY26.
Reader Takeaway: Operational turnaround achieved, but investment losses and market pressures remain.
What just happened
Nureca Limited has reported a significant operational turnaround in FY2025-26, moving from an operating loss of ₹7.5 crore to an operating profit of ₹8.5 crore. This was achieved alongside revenues of ₹146.96 crore. However, the company registered a net loss in Q4 FY26 due to an ₹83.50 million fair value loss on its investment portfolio.
Why this matters
This operational recovery signals improved business model viability and efficiency gains for Nureca. The company's debt-free status and strong liquidity further enhance its financial stability. However, the reported net loss in Q4, driven by investment valuation dips, highlights a potential area of concern for net earnings despite operational improvements.
The backstory
Nureca has been focused on improving its operational efficiencies. The company also executed a buyback of 4,58,255 equity shares at ₹330 per share in December 2025. Additionally, there have been senior leadership changes, with the resignation of CFO Naresh Gupta and the appointment of Chander Kant as the new CFO.
What changes now
The company is initiating a Scheme of Merger to absorb its wholly-owned subsidiary, Nureca Technologies Private Limited. This is aimed at streamlining organizational operations. The operational turnaround and merger signal a strategic push towards greater efficiency and control.
Risks to watch
Investors should monitor competitive pressures in the digital healthcare and quick-commerce sectors, which can lead to pricing and margin challenges. The impact of fair value losses on investment portfolios also needs to be watched to ensure it doesn't become a recurring drag on net profits.
Peer comparison
While specific peer data is not provided in the filing, Nureca operates in the competitive digital healthcare and quick-commerce space, where margin management and navigating pricing pressures are common challenges for all players.
Context metrics (time-bound)
- GMV (FY26): ₹203 crore
- Revenue from Operations (FY26): ₹146.96 crore
- Operating Profit (FY26): ₹8.5 crore
- Operating Profit (FY25): -₹7.5 crore (loss)
- PAT (FY26): ₹2.1 crore
- Q4 FY26 Fair Value Loss on Investments: ₹83.50 million (approx. ₹8.35 crore)
- Share Buyback: December 2025 at ₹330 per share
What to track next
Investors should focus on how Nureca manages its margins amidst market competition and whether the fair value losses on investments are isolated incidents or indicative of a larger trend. The success of the subsidiary merger in streamlining operations will also be a key factor.